Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PMN
PMN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PMN News
Phoenix Mecano Valued at CHF 769, Currently 44% Undervalued
Jan 18 2026
Yahoo Finance
Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers
Dec 19 2025
NASDAQ.COM
After-Hours Stock Surge: Exicure Leads with 72% Increase, Followed by Wave Life and Assembly Biosciences
Dec 09 2025
NASDAQ.COM
ProMIS Neurosciences CEO to Participate in Evercore Healthcare Conference on December 2, 2025
Dec 01 2025
Globenewswire
Dow Rises by 300 Points; Waldencast Stock Takes a Dive
Nov 24 2025
Benzinga
Nasdaq Rises by 350 Points; Enlivex Therapeutics Stock Jumps Significantly
Nov 24 2025
Benzinga
HC Wainwright & Co. Affirms Buy Rating for ProMIS Neurosciences, Keeps $4 Price Target Intact
Nov 21 2025
Benzinga
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
Sep 18 2025
PRnewswire
ProMIS Neurosciences seeks approval to sell 28.23 million common shares on behalf of shareholders.
Sep 04 2025
SeekingAlpha
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?
Aug 01 2025
Benzinga
Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket
Jul 23 2025
Benzinga
3 Penny Stocks to Watch Now, 7/22/25
Jul 22 2025
TipRanks
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Jul 21 2025
TipRanks
Nasdaq Surges Over 100 Points; Domino's Shares Fall After Q2 Results
Jul 21 2025
Benzinga
Dow Gains 50 Points; Verizon Earnings Top Views
Jul 21 2025
Benzinga
Why Is ProMIS Neurosciences Stock (PMN) Up 180% Today?
Jul 21 2025
TipRanks
Show More News
